Jacobs Levy Equity Management’s Dermira, Inc. DERM Stock Holding History

Jacobs Levy Equity Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-494,858	Closed	-$7.5M	–	1154
2019 Q4	$7.5M	Buy	494,858 +467,258	+1,693%	+$4.03M	0.07%	298
2019 Q3	$176K	Sell	27,600 -29,963	-52%	-$250K	﹤0.01%	857
2019 Q2	$550K	Sell	57,563 -706,027	-92%	-$7.6M	0.01%	727
2019 Q1	$10.3M	Buy	763,590 +310,551	+69%	+$2.59M	0.15%	178
2018 Q4	$3.26M	Buy	453,039 +437,239	+2,767%	+$4.78M	0.06%	352
2018 Q3	$172K	Buy	+15,800	New	+$159K	﹤0.01%	940

Jacobs Levy Equity Management's DERM Position: Q1 2020 in Review

Jacobs Levy Equity Management sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 494,858 shares — an estimated $7.5M sold.

Jacobs Levy Equity Management first reported a position in DERM in Q3 2018 and held it in 6 quarters. The position peaked at $10.3M in Q1 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Jacobs Levy Equity Management reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Jacobs Levy Equity Management sold 494,858 Dermira, Inc. shares in Q1 2020, an estimated $7.5M.
Jacobs Levy Equity Management first reported a position in Dermira, Inc. in Q3 2018 and held it in 6 quarters.
Jacobs Levy Equity Management's Dermira, Inc. position peaked at $10.3M in Q1 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2020, filed 15 May 2020.